Navigation Links
Nanogen Issued Patent for Electronic Microarray With Memory

Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it was issued U.S. Patent No. 6,867,048, "Multiplexed Active Biologic Array" by the U.S. Patent and Trademark Office. The '048 patent relates to a method of addressing one or more electrodes (or "test sites") across multiple rows and columns of a microarray. The patent also covers a method for storing the value of the voltage associated with each electrode in a local memory. This "smart chip" technology is a key feature of Nanogen's NanoChip(R) 400 electronic microarray, the company's second generation multi-purpose system for developing and performing molecular diagnostic tests.

Using local memory circuits provides for precise control of the currents delivered to individual electrodes on the array, while minimizing the utilization of "off-chip" circuitry and overall system costs. The electric potential is controlled at each of the NanoChip's 400 test sites to move and concentrate DNA or RNA, providing accuracy, speed and flexibility for developing molecular diagnostic tests. Storing critical voltage information allows for precise control of the biological molecules during analysis and increases data management efficiency by tracking test site activation and array usage directly on the electronic microarray cartridge.

"This addition to our growing intellectual property portfolio illustrates our ability to develop differentiated advanced diagnostic products that add value to the company and to research and clinical laboratory customers," said Howard C. Birndorf, Nanogen chairman of the board and CEO.

This new patent expands Nanogen's intellectual property portfolio to include 114 patents issued in the U.S.

About Nanogen, Inc.

Nanogen's advanced diagnostics provide physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and relia ble NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop tests to detect infectious diseases, drug toxicity and mutations associated with cancer, cardiovascular and genetic diseases. The next generation instrument system, the NanoChip(R) 400, is expected to be available in 2005. Nanogen's subsidiary SynX offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. For additional information please visit Nanogen's website at



Related biology news :

1. Dinosaur DNA? New Patent Covers Degraded DNA recovery
2. Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics
3. Electronic chip, interacting with the brain, modifies pathways for controlling movement
4. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
5. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. Characterizing Skin Cancer by Microarrays
8. Microarrays as phenotype
9. $6.5 Million Grant for Microarray Center at Yale School of Medicine
10. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
11. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
Post Your Comments:

(Date:11/4/2015)... , November 4, 2015 ... market report published by Transparency Market Research "Home Security Solutions ... and Forecast 2015 - 2022", the global home security solutions ... bn by 2022. The market is estimated to expand ... from 2015 to 2022. Rising security needs among customers ...
(Date:10/29/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that it has ... as one of only three finalists for a ... and Growing" category. The Tekne Awards honor Minnesota ... technology innovation and leadership. iMedNet™ eClinical ...
(Date:10/29/2015)... Va. , Oct. 29, 2015 Daon, ... today that it has released a new version of ... customers in North America have ... IdentityX v4.0 also includes a FIDO UAF certified ... are already preparing to activate FIDO features. These customers ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... , ... November 24, 2015 , ... This fall, global ... competitive events in five states to develop and pitch their BIG ideas to improve ... each state are competing for votes to win the title of SAP's Teen Innovator, ...
(Date:11/24/2015)... -- Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting ... Israel time, at the law offices of ... th Floor, Tel Aviv, Israel . ... Izhak Tamir to the Board of Directors; , election of ... approval of an amendment to certain terms of options granted to our ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and assessment ... Chief Operating Officer. , Having joined InSphero in November 2013 as Business ... to Head of InSphero Diagnostics in 2014. There she has built up the ...
(Date:11/24/2015)... 2015 HemoShear Therapeutics, LLC, a privately ... metabolic disorders, announced today the appointment of ... Directors (BOD). Mr. Watkins is the former president ... (HGS), and also served as the chairman of ... , Chairman and CEO of HemoShear Therapeutics. "The ...
Breaking Biology Technology: